Debt mutual fund checklist
Debt mutual fund checklist

Debt mutual fund checklist

Henil Shah Article rating: 5.0

Before closing a deal or starting any activity going through a checklist helps us make sure everything is in place and okay. So, what are the things that you must check before investing in debt funds? Let’s find out.

VA Tech Wabag zooms 8 per cent on order win
VA Tech Wabag zooms 8 per cent on order win

VA Tech Wabag zooms 8 per cent on order win

Shohini Nath Article rating: 5.0

VA Tech Wabag has bagged order worth Rs. 1,187 crore from Bihar Urban Infrastructure Development Corporation (BUIDCO). The order falls under the prestigious National Mission for Clean Ganga (NMCG) Scheme.


Supreme Court appoints NBCC to complete Amrapali projects
Supreme Court appoints NBCC to complete Amrapali projects

Supreme Court appoints NBCC to complete Amrapali projects

Gayathri Udyawar Article rating: 5.0

The apex court orders the cancellation of the RERA registration of Amrapali Group and directs ED to investigate the company for money laundering. State-owned real estate developer NBCC India was appointed by the Supreme Court (SC) to complete the unfinished projects taken up by the builder.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on July 23, 2019 opened gap down. BSE Sensex is trading at 38,097.54, up by 66.41 points and the Nifty is trading at 11,348.15, up by 1.95 points. 

Blue Star secures order for Mumbai Metro Rail
Blue Star secures order for Mumbai Metro Rail

Blue Star secures order for Mumbai Metro Rail

Nidhi Jani Article rating: 5.0

The order would further expand the company’s EMP and Packaged Air Conditioning system segment revenue, going ahead. The order book of EMP and Packaged Air Conditioning system segment as on FY19 stood at Rs. 2,952 core which translates book-to-bill of 1.1x on FY19 revenue giving healthy revenue visibility in the near term.

Alembic Pharma advances 5 per cent on USFDA approval
Alembic Pharma advances 5 per cent on USFDA approval

Alembic Pharma advances 5 per cent on USFDA approval

Amir Shaikh Article rating: 5.0

Gujarat-based pharmaceutical company Alembic Pharma today informed the bourses that it has received tentative approval from US Food & Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 2.5

Overall volumes in futures & options currently stand at 1,56,71,937 contracts with a turnover of Rs.10,63,981.45 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 3.5

Overall volumes in futures & options currently stand at 1,56,71,937 contracts with a turnover of Rs.10,63,981.45 crore.

Index trend and stocks in action July 23, 2019
Index trend and stocks in action July 23, 2019

Index trend and stocks in action July 23, 2019

Karan Dsij Article rating: 5.0

We believe holding above the Monday’s session low of 11,300 could mean a possibility of an upside bounce in the index. On the downside, if the index slips and sustains below the 11,300 mark, it would lead to an extension of the correction towards the 11,220 mark. Stocks in news: Alphageo, Kinetic Engineering, TVS Motor, BSE, Vadilal Industries.

RSS
First24992500250125022504250625072508Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR